Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment

Two open-label, single-dose, parallel-group studies were conducted to characterize the pharmacokinetics of the novel antibacterial tedizolid and the safety of tedizolid phosphate, its prodrug, in renally or hepatically impaired subjects. Tedizolid pharmacokinetics in subjects with severe renal impai...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Flanagan, S., Minassian, S. L., Morris, D., Ponnuraj, R., Marbury, T. C., Alcorn, H. W., Fang, E., Prokocimer, P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249404/
https://ncbi.nlm.nih.gov/pubmed/25136024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03431-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi